Atosiban

Immunogen Synthetic peptide directed towards the N terminal region of human ATIC Application Anti-ATIC (AB2) antibody produced in rabbit is suitable for western blotting at a concentration of 1.25&#956g/ml.

General description Sphingosine 1-phosphate receptor 2 (S1PR2), otherwise known as EDG5, is a ubiquitous G-protein coupled receptor for lysosphingolipid sphingosine 1-phosphate (S1P). It is coupled to Gi, G12/13, and Gq pathways to regulate a

AT

Atglistatin

Atglistatin

ATH 1ML V1

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

IL-11, Interleukin-11, murine (mouse): Interleukin 11 is a pleiotropic cytokine that was originally detected in the conditioned medium of an IL-1&alpha-stimulated primate bone marrow stromal cell line (PU-34) as a mitogen for the IL-6-responsive

IL-11, Interleukin-11, murine (mouse): Interleukin 11 is a pleiotropic cytokine that was originally detected in the conditioned medium of an IL-1&alpha-stimulated primate bone marrow stromal cell line (PU-34) as a mitogen for the IL-6-responsive

Atosiban is an antagonist at oxytocin and vasopressin receptors, exhibiting tocolytic activity. Atosiban is clinically used to decrease uterine contractility in the prevention of preterm birth.

Atosiban is an antagonist at oxytocin and vasopressin receptors, exhibiting tocolytic activity. Atosiban is clinically used to decrease uterine contractility in the prevention of preterm birth.

Atosiban is an antagonist at oxytocin and vasopressin receptors, exhibiting tocolytic activity. Atosiban is clinically used to decrease uterine contractility in the prevention of preterm birth.